New framework for tracking cannabis-impaired driving across America

A multi-state methodological framework for behavioral surveillance of cannabis-impaired driving.

Traffic injury prevention • • Moderately Relevant
🤖

AI Summary

The Cannabis and Roadway Safety Study (CARSS) Phase 2 represents a major methodological advancement in how researchers track and understand cannabis-impaired driving across the United States. This multi-state project surveyed 2,023 cannabis-using drivers across eight states with different legal cannabis regulations—from prohibition to medical-only to recreational access. The study used innovative techniques including real-time demographic monitoring, AI-assisted qualitative analysis, and sophisticated weighting methods to ensure the data accurately represents current cannabis users in each state, addressing long-standing limitations in existing surveillance systems.

The research framework successfully demonstrated the feasibility of collecting detailed behavioral data on cannabis use patterns, driving habits, impairment beliefs, and public health messaging preferences in a standardized way across diverse regulatory environments. Each state achieved its target sample of approximately 250 respondents through quota sampling aligned with 2020 U.S. Census data, with recruitment fielding adjusted based on state-specific dynamics. The integration of AI-assisted open-text responses across all eight states proved particularly valuable for capturing nuanced information that traditional surveys often miss, providing richer qualitative insights alongside quantitative metrics.

This comprehensive methodological framework establishes a scalable blueprint for ongoing cannabis-impaired driving surveillance and public health research. By accounting for differences in state legal contexts and using responsive, real-time monitoring techniques, CARSS Phase 2 enables more accurate tracking of how cannabis use correlates with driving behaviors and risk perception. These findings will inform evidence-based policy decisions and targeted public health interventions designed to address cannabis-impaired driving, a growing public health concern in states where cannabis access has expanded.

📄 Original Abstract

Driving under the influence of cannabis is a growing public health concern in the United States. Existing surveillance systems often lack behavioral detail, rely on static quotas, or fail to account for differences across legal contexts. The Cannabis and Roadway Safety Study (CARSS) is a multi-phase project designed to address these gaps. This paper describes the methods of the Phase 2 questionnaire. A cross-sectional, mixed-methods questionnaire assessed cannabis use patterns, driving behaviors, impairment beliefs, and messaging preferences among adult drivers who currently use cannabis. The study employed a structured online questionnaire incorporating quantitative items and AI-assisted qualitative probes. Screening, quota sampling, and rake weighting were used to achieve state-level demographic representation based on 2020 U.S. Census benchmarks, with real-time monitoring. A secondary weighting step aligned full questionnaire participants with adult drivers who currently use cannabis within each state. The framework was implemented across eight U.S. states representing non-medical, medical-only, and prohibition policy environments, with data collection from November 28, 2023, to February 13, 2024. All states achieved target sample sizes of approximately 250 respondents, yielding a total analytic sample of 2,023 participants. Recruitment dynamics varied by state, with some requiring extended fielding to meet demographic targets. Usable open-text responses were obtained in all states through AI-assisted probing across policy environments. CARSS Phase 2 demonstrates the feasibility of integrating responsive quota monitoring, multi-step weighting, and AI-assisted qualitative probing into a scalable, multi-state surveillance framework for cannabis-impaired driving research and related public health.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.